Mostrando 4 resultados de: 4
Filtros aplicados
Área temáticas
Enfermedades(4)
Farmacología y terapéutica(1)
Fisiología humana(1)
Medicina y salud(1)
Psicología aplicada(1)
Área de conocimiento
Inmunología(1)
Metabolismo(1)
Nutrición(1)
Salud mental(1)
Trastorno depresivo mayor(1)
Origen
scopus(4)
Diagnostic criteria and management of metabolic syndrome: Evolution overtime
ReviewAbstract: The beginnings of the Metabolic Syndrome (MetS) as a suspected, not yet recognized entity can be traPalabras claves:Cardiovascular disease, Diagnostic criteria, management, Metabolic syndrome, MetS updates, Type 2 DiabetesAutores:Carrasquero R., Castro A., Lameda V., Manzano A., Nava M., Rojas E.R., Suarez M.K., Valmore BermúdezFuentes:scopusDepression as an immunometabolic disorder: Exploring shared pharma-cotherapeutics with cardiovascular disease
ReviewAbstract: Modern times have seen depression and cardiovascular disease (CVD) become notorious public health coPalabras claves:Cardiovascular disease, Chronic inflammation, Depression, Insulin Resistance, metabolism, Oxidative StressAutores:Chávez-Castillo M., Nava M., Nuñez V., Ortega A., Rojas M., Rojas-Quintero J., Salazar-Vílchez J., Valmore BermúdezFuentes:scopusHypertension, emotions and happiness: A brief view from the biology to the positive psychology
ArticleAbstract: High blood pressure (HBP) is a silent disease with an extremely high prevalence worldwide. It is conPalabras claves:Cardiovascular disease, happiness, HEALTH, Hypertension, psychosocialAutores:Bautista-Sandoval M.J., Castro A., Chaparro-Suárez Y.K., Díaz-Camargo E.A., Durán P., D’marco L., González M.C., Nava M., Ortiz O.M., Parra H., Riaño-Garzón M.E., Rojas E.R., Valmore BermúdezFuentes:scopusMetabolic risk in depression and treatment with selective serotonin reuptake inhibitors: are the metabolic syndrome and an increase in cardiovascular risk unavoidable?
ReviewAbstract: Depression is one of the most common psychiatric disorders, and has become an epidemic in modern medPalabras claves:Cardiovascular disease, Cardiovascular Risk, Chronic inflammation, Depression, Metabolic syndrome, Selective serotonin reuptake inhibitors, Type 2 Diabetes mellitusAutores:Chávez-Castillo M., Fuenmayor J., Lameda V., Nava M., Ortega A., Rojas-Quintero J., Valmore Bermúdez, Velasco M.Fuentes:scopus